| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.38 | 4e-08 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.35 | 3e-07 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-07 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |